文献速递气道管理术前评估与围术期医学

右美托咪定联合利多卡因表面麻醉对甲状腺切除术拔管期呛咳反射的影响:随机临床试验

Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patients: A Randomized Clinical Trial.
PubMed 文献 · Anesth Analg · 2025-05-08

该随机对照试验纳入180例18至65岁择期全麻甲状腺切除术女性患者,比较右美托咪定联合利多卡因喷雾、单用利多卡因及生理盐水对拔管期呛咳反射的影响。结果显示联合组拔管期呛咳发生率显著低于单用利多卡因组和对照组,且联合组呛咳严重程度显著低于对照组,并可减少术后咽痛、稳定血流动力学。

要点

  • 右美托咪定联合利多卡因喉咽喷雾可显著降低甲状腺切除术患者拔管期呛咳发生率。
  • 联合组呛咳发生率23%,低于单用利多卡因组的47%和对照组的70%。
  • 联合方案还能减轻术后咽痛并稳定血流动力学。

核心结论

  • 右美托咪定联合利多卡因喉咽喷雾可有效抑制甲状腺切除术女性患者拔管期呛咳反射,减少术后咽痛并稳定血流动力学。

研究设计与样本

  • 随机对照试验,纳入180例18至65岁择期全麻甲状腺切除术女性患者,随机分为右美托咪定联合利多卡因组(n=60)、单用利多卡因组(n=60)和生理盐水对照组(n=60)。

主要发现

  • 拔管期呛咳发生率联合组23% vs 对照组70%(OR 0.13,95%CI 0.06-0.29,P<.001),单用利多卡因组47% vs 对照组70%(OR 0.38,95%CI 0.18-0.79,P=.010)。
  • 联合组与单用利多卡因组呛咳发生率差异有统计学意义(23% vs 47%,OR 0.35,95%CI 0.16-0.76,P=.007)。
  • 联合组呛咳严重程度显著低于对照组(8/60 vs 26/60,OR 0.20,95%CI 0.08-0.50,P<.001)。

关键数值与推荐

  • 右美托咪定联合2%利多卡因喷雾于声门上、声门及声门下区域,单用利多卡因组予2%利多卡因喷雾,对照组予0.9%生理盐水喷雾。
  • 主要结局为拔管期呛咳反射发生率;次要结局包括呛咳严重程度、术后咽痛、声嘶、恶心呕吐、镇痛止吐药需求、疼痛评分、镇静评分及住院时间。

临床怎么用

  • 对于全麻甲状腺切除术女性患者,拔管前可考虑右美托咪定联合利多卡因喉咽喷雾以降低拔管期呛咳风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cough reflex during extubation can lead to complications such as increased bleeding and hemodynamic instability, especially in thyroidectomy, therefore, effective suppression of cough reflex is clinically important. The aim of the study was to investigate the inhibitory effect of dexmedetomidine combined with lidocaine on the cough reflex during extubation in thyroidectomy. METHODS: A total of 180 female patients, aged 18 to 65 years, undergoing elective thyroidectomy under general anesthesia, were randomized into 3 groups: dexmedetomidine combined with lidocaine (Dex-Lido group, n = 60), lidocaine alone (Lido group, n = 60), or normal saline (Control group, n = 60). Before tracheal intubation, patients in the Dex-Lido group received dexmedetomidine combined with 2% lidocaine spray, those in the Lido group received 2% lidocaine spray, and those in the Control group received 0.9% normal saline spray, applied to the supraglottic, glottic, and subglottic areas. The primary outcome was the incidence of cough reflex at extubation. Secondary outcomes included cough severity, postoperative sore throat, hoarseness, nausea, and vomiting, as well as the need for analgesics and antiemetics, pain levels, sedation scores, and length of hospital stay. RESULTS: The incidence of cough reflex during extubation was significantly lower in both the Dex-Lido and Lido groups compared to the Control group (23% vs 70%; odds ratio [OR], 0.13; 95% confidence interval [CI], 0.06-0.29; P < .001 for Dex-Lido; 47% vs 70%; OR, 0.38; 95% CI, 0.18-0.79]; P = .010 for Lido), with a statistically significant difference between the Dex-Lido and Lido groups (23% vs 47%; OR, 0.35; 95% CI, 0.16-0.76; P = .007). Additionally, the severity of the cough reflex was markedly lower in the Dex-Lido group compared to the Control group (8/60 vs 26/60; OR, 0.20; 95% CI, 0.08-0.50; P < .001). CONCLUSIONS: The combination of dexmedetomidine and lidocaine laryngopharynx spray effectively suppresses the cough reflex during extubation, reduces postoperative sore throat, and stabilizes hemodynamics in female patients undergoing thyroid surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Wang K, Wei B, Wang X, et al. Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patients: A Randomized Clinical Trial. Anesth Analg. 2025. PMID: 40338875. doi:10.1213/ANE.0000000000007560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。